Maternal circulating levels of some metabolic syndrome biomarkers in gestational diabetes mellitus
- 474 Downloads
The aims of the present study were to explore serum levels of lipid profile, atherogenic indexes LDL-C/HDL-C, TG/HDL-C, and TC/HDL-C, bilirubin, adiponectin, pseudocholinesterase, activities of gamma-glutamyltransferase (GGT), adenosine deaminase (ADA), and α-amylase, insulin resistance using homeostasis model assessment of insulin resistance (HOMA-IR) formula, and assessment of correlations between them in gestational diabetes mellitus (GDM) compared with normal pregnancy. A cross-sectional study was designed. The patients consisted of 30 women with GDM. The normal group consisted of 30 healthy pregnant women. The Mann–Whitney U test and Spearman’s correlation analysis were used for statistical analysis. A p value less than 0.05 was considered significant. Serum activities of enzymes GGT (p = 0.001) and ADA (p = 0.02) were significantly higher in GDM compared with normal pregnancy, while pseudocholinesterase were significantly decreased (p = 0.02). However, activity of enzyme α-amylase did not show significant difference between two groups (p = 0.75). Serum levels of both HDL-C and adiponectin were significantly decreased in GDM group (p = 0.001). The atherogenic indexes and the HOMA-IR index were significantly higher in GDM (p = 0.001). Serum activity of ADA showed positive correlation with total cholesterol (TC) (r = 0.46, p = 0.01) and CRP (r = 0.66, p = 0.001) in GDM group. Serum levels of total bilirubin correlated negatively with both ADA (r = −0.38, p = 0.04) and triglyceride (r = −0.45, p = 0.01) in women with GDM. Serum activity of GGT correlated positively with LDL-C (r = 0.48, p = 0.01) and TC (r = 0.52, p = 0.003) in GDM group. Increased atherogenic indexes, ADA, GGT, and decreased pseudocholinesterase might be risk factors for GDM.
KeywordsAdenosine deaminase Amylase Atherogenic index Gamma-glutamyltransferase Insulin resistance Gestational diabetes mellitus
This research was supported by a grant from Lorestan University of Medical Sciences (No. 61–91).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- 2.M.I. Yeral, A.S. Ozgu-Erdinc, D. Uygur, K.D. Seckin, M.F. Karsli, A.N. Danisman, Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial. Endocrine 46, 512–518 (2014)CrossRefPubMedGoogle Scholar
- 15.K.S. De Bona, G. Bonfanti, P.E. Bitencourt, L.O. Cargnelutti, P.S. da Silva, L. De Lucca, V.C. Pimentel, E. Tatsch, T.L. Gonçalves, M. Premaor, R.N. Moresco, M.B. Moretto, Butyrylcholinesterase and γ-glutamyltransferase activities and oxidative stress markers are altered in metabolic syndrome, but are not affected by body mass index. Inflammation 36, 1539–1547 (2013)CrossRefPubMedGoogle Scholar
- 16.N.G. Vallianou, A.A. Evangelopoulos, V. Bountziouka, M.S. Bonou, C. Katsagoni, E.D. Vogiatzakis, P.C. Avgerinos, J. Barbetseas, D.B. Panagiotakos, Association of butyrylcholinesterase with cardiometabolic risk factors among apparently healthy adults. J. Cardiovasc. Med. (Hagerstown) 15, 377–383 (2014)CrossRefGoogle Scholar
- 18.L.O. Guimarães, F.A. de Andrade, G.F. Bono, T.E. Setoguchi, M.B. Brandão, E.A. Chautard-Freire-Maia, I.C. Dos Santos, G. Picheth, A.C. Faria, R.R. Réa, R.L. Souza, L. Furtado-Alle, Gestational diabetes mellitus (GDM) decreases butyrylcholinesterase (BChE) activity and changes its relationship with lipids. Genet. Mol. Biol. 37, 1–6 (2014)CrossRefPubMedPubMedCentralGoogle Scholar